Thalia Therapeutics Plc (0GO)
FSX
Real-time Data
06:00 AM
Day's Range
0.0080052 wk Range
0.00050Overview - 0GO - Thalia Therapeutics Plc
Key Statistics
Valuation
Enterprise Value
6.51M
P/E (Trailing)
‪-4.70‬
Price / Sales (TTM)
‪1,955.63‬
Price / Book
‪6.85‬
EV / EBITDA
‪-5.06‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-19,446.16%‬
Return on Assets
‪-74.91%‬
Return on Equity
‪-140.32%‬
Ownership
Shares Outstanding
832.28M
Float
105.74M
Held by Insiders
‪58.65%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.72‬
50-Day Avg
‪0.00483‬
200-Day Avg
‪0.00193‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0GO - Thalia Therapeutics Plc
Peers - 0GO - Thalia Therapeutics Plc
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
Profile Summary - 0GO - Thalia Therapeutics Plc
About
Thalia Therapeutics Plc is a biotechnology company developing RNA-based therapeutics and delivery technologies for oncology and cardiovascular disease. The company's proprietary Nuvec delivery system uses amorphous silica nanoparticles with an irregular surface structure designed to trap, protect, and deliver RNA…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
